Showing items 1–100
Cyclic di-nucleotide induction of type I interferon
Grant US-11873319-B2
United States of America
CANCER VACCINES AND METHODS OF USE THEREOF
Application WO-2023167973-A1
World Intellectual Property Organisation (WIPO)
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its…
Grant US-11369691-B2
United States of America
Compositions comprising lentiviral vectors expressing IL-12 and methods of use thereof
Grant US-11365230-B2
United States of America
Retroviral vector for the administration and expression of replicon RNA expressing…
Grant US-11135283-B2
United States of America
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its…
Grant US-11135312-B2
United States of America
Survivin-derived peptides and uses thereof
Grant US-RE48522-E1
United States of America
Treatment or prevention of melanoma using photochemical internalization of a melanoma…
Grant US-10973896-B2
United States of America
Bacterial vaccines deficient in the 2-C-methyl-D-erythritol-4-phosphate pathway and…
Grant US-10925945-B2
United States of America
Modified RNA with decreased immunostimulatory properties
Grant US-10898584-B2
United States of America
COMPOSITIONS COMPRISING LENTIVIRAL VECTORS EXPRESSING IL-12 AND METHODS OF USE THEREOF
Application EP-3738973-A1
European Patent Office
Anti-HCTLA-4 antibodies
Grant US-10808030-B2
United States of America
Engineered nucleic acids and methods of use thereof
Grant US-10751386-B2
United States of America
SELF-ASSEMBLED PEPTIDE NANOPARTICLE AND USE THEREOF
Application WO-2020146906-A2
World Intellectual Property Organisation (WIPO)
Compositions and methods for improved car-T cell therapies
Grant US-10688166-B2
United States of America
Compositions and methods for activating “stimulator of interferon gene”-dependent…
Grant US-10653774-B2
United States of America
Multigenome retroviral vector preparations and methods and systems for producing and…
Grant US-10584356-B2
United States of America
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its…
Grant US-10568972-B2
United States of America
Modified polynucleotides
Grant US-10501512-B2
United States of America
Anti-PD-1 antibodies
Grant US-10494436-B2
United States of America
Compositions comprising cyclic purine dinucleotides having defined stereochemistries and…
Grant US-10414789-B2
United States of America
Polynucleotides encoding low density lipoprotein receptor
Grant US-10323076-B2
United States of America
ABERRANT CELL-RESTRICTED IMMUNOGLOBULINS PROVIDED WITH A TOXIC MOIETY
Application EP-3470434-A1
European Patent Office
Compositions and methods for inhibiting “stimulator of interferon gene”-dependent…
Grant US-10189873-B2
United States of America
Multigenome retroviral vector preparations and methods and systems for producing and…
Grant US-10179919-B2
United States of America
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
Grant US-10064959-B2
United States of America
Engineered nucleic acids and methods of use thereof
Grant US-10022425-B2
United States of America
Vectors for molecule delivery to CD11b expressing cells
Grant US-10004794-B2
United States of America
Delivery and formulation of engineered nucleic acids
Grant US-9950068-B2
United States of America
Packaging of immunostimulatory substances into virus-like particles: method of…
Grant US-9950055-B2
United States of America
Engineered nucleic acids and methods of use thereof
Grant US-9937233-B2
United States of America
Methods and compositions using Listeria for enhancing immunogenicity by prime boost
Grant US-9878024-B2
United States of America
Modified polynucleotides for the production of cosmetic proteins and peptides
Grant US-9878056-B2
United States of America
Modified polynucleotides for the production of secreted proteins
Grant US-9828416-B2
United States of America
Modified polynucleotides for the production of proteins
Grant US-9827332-B2
United States of America
Modified polynucleotides for the production of biologics and proteins associated with…
Grant US-9814760-B2
United States of America
Modified polynucleotides for the production of proteins associated with human disease
Grant US-9782462-B2
United States of America
Compositions and methods for cancer immunotherapy
Grant US-9770467-B2
United States of America
Compositions and methods for activating stimulator of interferon gene-dependent signalling
Grant US-9724408-B2
United States of America
Engineered nucleic acids and methods of use thereof
Grant US-9701965-B2
United States of America
Compositions comprising cyclic purine dinucleotides having defined stereochemistries and…
Grant US-9695212-B2
United States of America
Modified polynucleotides encoding hepatitis A virus cellular receptor 2
Grant US-9675668-B2
United States of America
Signal peptide fusion partners facilitating listerial expression of antigenic sequences…
Grant US-9663557-B2
United States of America
Application of mRNA for use as a therapeutic against tumour diseases
Grant US-9655955-B2
United States of America
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
Grant US-9657295-B2
United States of America
Compositions capable of specifically binding particular human antigen presenting molecule/p…
Grant US-9616112-B2
United States of America
Terminally modified RNA
Grant US-9597380-B2
United States of America
Modified polynucleotides for the production of oncology-related proteins and peptides
Grant US-9587003-B2
United States of America
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
Grant US-9572897-B2
United States of America
Compositions and methods for inhibiting “stimulator of interferon gene”—dependent…
Grant US-9549944-B2
United States of America
Survivin-derived peptides and uses thereof
Grant US-9534030-B2
United States of America
Delivery and formulation of engineered nucleic acids
Grant US-9533047-B2
United States of America
Facultatively attenuated bacterial species and methods of preparation and use thereof
Grant US-9511129-B2
United States of America
Engineered nucleic acids and methods of use thereof
Grant US-9464124-B2
United States of America
Application of mRNA for use as a therapeutic against tumour diseases
Grant US-9463228-B2
United States of America
Engineered nucleic acids and methods of use thereof
Grant US-9447164-B2
United States of America
Application of mRNA for use as a therapeutic against tumour diseases
Grant US-9439956-B2
United States of America
Application of mRNA for use as a therapeutic against tumor diseases
Grant US-9433669-B2
United States of America
Application of mRNA for use as a therapeutic against tumour diseases
Grant US-9433670-B2
United States of America
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
Grant US-9428535-B2
United States of America
Recombinant adenylate cyclase toxin of bordetella induces T cell responses against…
Grant US-9410139-B2
United States of America
Vectors for molecule delivery to CD11b expressing cells
Grant US-9370564-B2
United States of America
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
Grant US-9334328-B2
United States of America
Modified polynucleotides encoding apoptosis inducing factor 1
Grant US-9301993-B2
United States of America
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
Grant US-9303079-B2
United States of America
Formulation and delivery of PLGA microspheres
Grant US-9295689-B2
United States of America
Modified polynucleotides for the production of nuclear proteins
Grant US-9283287-B2
United States of America
Formulation and delivery of PLGA microspheres
Grant US-9271996-B2
United States of America
Modified polynucleotides encoding SIAH E3 ubiquitin protein ligase 1
Grant US-9255129-B2
United States of America
Modified polynucleotides for the production of proteins
Grant US-9254311-B2
United States of America
Modified polynucleotides for the production of proteins associated with blood and…
Grant US-9233141-B2
United States of America
In vivo production of proteins
Grant US-9221891-B2
United States of America
Modified polynucleotides for the production of proteins associated with blood and…
Grant US-9220755-B2
United States of America
Modified polynucleotides encoding aquaporin-5
Grant US-9220792-B2
United States of America
Modified polynucleotides encoding granulysin
Grant US-9216205-B2
United States of America
Modified polynucleotides for the production of secreted proteins
Grant US-9192651-B2
United States of America
Split dose administration
Grant US-9186372-B2
United States of America
Application of mRNA for use as a therapeutic against tumour diseases
Grant US-9155788-B2
United States of America
Modified polynucleotides encoding septin-4
Grant US-9149506-B2
United States of America
Modified polynucleotides encoding citeD4
Grant US-9114113-B2
United States of America
Modified polynucleotides encoding basic helix-loop-helix family member E41
Grant US-9107886-B2
United States of America
Antigen-presenting complex-binding compositions and uses thereof
Grant US-9095533-B2
United States of America
Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1
Grant US-9095552-B2
United States of America
Modified polynucleotides for treating galactosylceramidase protein deficiency
Grant US-9089604-B2
United States of America
Modified polynucleotides for treating protein deficiency
Grant US-9061059-B2
United States of America
Modified polynucleotides encoding aryl hydrocarbon receptor nuclear translocator
Grant US-9050297-B2
United States of America
Immunogenic compositions and methods of using the compositions for inducing humoral and…
Grant US-9044420-B2
United States of America
Compositions capable of specifically binding particular human antigen presenting molecule/p…
Grant US-9023348-B2
United States of America
Survivin-derived peptides and use thereof
Application EP-2857035-A1
European Patent Office
Modified polynucleotides for the production of biologics and proteins associated with…
Grant US-8999380-B2
United States of America
Compositions and methods of altering cholesterol levels
Grant US-8980864-B2
United States of America
Engineered nucleic acids and methods of use thereof
Grant US-8822663-B2
United States of America
DLIN-KC2-DMA lipid nanoparticle delivery of modified polynucleotides
Grant US-8754062-B2
United States of America
Anti human immunodeficiency antibodies and uses thereof
Grant US-8747855-B2
United States of America
Engineered nucleic acids encoding a modified erythropoietin and their expression
Grant US-8710200-B2
United States of America
Packaging of immunostimulatory substances into virus-like particles: method of…
Grant US-8691209-B2
United States of America
Modified polynucleotides for the production of G-CSF
Grant US-8680069-B2
United States of America
Methods and compositions to elicit multivalent immune responses against dominant and…
Grant US-8674081-B2
United States of America
Method for producing a protein of interest in a primate
Grant US-8664194-B2
United States of America
Showing items 1–100